dsdsa

product

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

The customer satisfaction is our primary target. We uphold a consistent level of professionalism, quality, credibility and service for Yohimbine Hydrochloride, Tofacitinib Citrate Api, 7413-34-5, We are willing to give you the best suggestions on the designs of your orders in a professional way if you need. In the meantime, we keep on developing new technologies and creating new designs so as to make you ahead in the line of this business.
Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai Detail:

Product name Entecavir monohydrate
Synonyms 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate
CAS No. 209216-23-9
Appearance White to off-white powder
Molecular Formula C12H15N5O3.H2O
Molecular Weight 295.30
Usage Pharmaceutical Grade or Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Entecavir monohydrate Cas: 209216-23-9

Items

Standard

Results

Appearance White to off-white powder Complies
Optical rotation +24.0°—+28.0°(DMF:MeOH=1:1 c=1%) +27.0°
Identification A: By IR, To match with working standard Complies
B: By HPLC,retain time should match with working standard Complies
Water 5.8%—6.5% 6.1%
Isomer Single ≤0.1% 0.02%
Total ≤0.5% 0.02%
Related Substances Single impurity ≤0.1% 0.05%
Total impurities ≤0.3% 0.07%
Residue on ignition ≤0.1% 0.04%
Heavy metals £ 10ppm Complies
Residual  solvents Should be to match with the standard Complies
Assay ≥99.8% 99.9%
Conclusion:Complies to the in-house standards.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures


Related Product Guide:

Our corporation has been specializing in brand strategy. Customers' gratification is our greatest advertising. We also source OEM company for Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai , The product will supply to all over the world, such as: Adelaide, Egypt, Provence, We believe that good business relationships will lead to mutual benefits and improvement for both parties. We have established long-term and successful cooperative relationships with many customers through their confidence in our customized services and integrity in doing business. We also enjoy a high reputation through our good performance. Better performance will be expected as our principle of integrity. Devotion and Steadiness will remain as ever.
  • The quality of the products is very good, especially in the details, can be seen that the company work actively to satisfy customer's interest, a nice supplier.
    5 Stars By Mario from Milan - 2018.11.06 10:04
    The sales manager has a good English level and skilled professional knowledge, we have a good communication. He is a warm and cheerful man, we have a pleasant cooperation and we became very good friends in private.
    5 Stars By Jean from Egypt - 2018.09.23 17:37
    Write your message here and send it to us